Accordingly, the effect of the UGT1A1 and OATP1B1 inhibitor atazanavir [18] on bilirubin levels was evaluated using models for healthy individuals and patients with Gilbert syndrome. Here, SLCO1B1 is linked to Gilbert syndrome.